Where does Eli Casdin work?

Eli Casdin is Chief Investment Officer and Founder at Casdin Capital and Board director at C2i Genomics and Board director at Sexton Biotechnologies and Board director at Century Therapeutics, Inc..

What check size does Eli Casdin write?

Eli Casdin typically writes checks of $100K – $5M.

What boards does Eli Casdin sit on?

Eli Casdin holds tracked board seats at Absci, C2i Genomics, Cedilla Therapeutics, Inc., Century Therapeutics, Inc., Genomatica, PAIGE.AI, Inc., SomaLogic, Vitruvian Networks.

What companies has Eli Casdin invested in?

Investments tracked here include Absci, C2i Genomics, Cedilla Therapeutics, Century Therapeutics, Inc., DNA Script, Leyden Labs, Multiply Labs, SomaLogic, Standard BioTools, Tenaya Therapeutics, Thrive Earlier Detection, Verve Therapeutics, and 1 more.

Where did Eli Casdin go to school?

Eli Casdin studied at Columbia Business School (MBA, Finance - Accounting); Columbia University (Bachelor of Science); University of Vermont.

Eli Casdin

Investor

Chief Investment Officer and Founder at Casdin Capital · Board director at C2i Genomics · Board director at Sexton Biotechnologies · Board director at Century Therapeutics, Inc.

New York, New York

Writes $100K – $5M checks · typically $1.5M

Find your path to Eli

692 people in our graph share verified history with Eli — schools, employers, funds. One of them is your warm intro.

Peter ChungunlockedEli: together at Columbia University (2001–2003)

×3Eli: together at Columbia University

×2Eli: together at Bear Stearns

Eli: together at The Rockefeller University

About

Eli Casdin authored mid-2000s roadmap The Dawn of Molecular Medicine and backs platforms using biological data as decision-making infrastructure while guiding companies to markets via co‑sponsored CM Life Sciences SPACs.

Contact· self-published, not guessed

e•••@casdincapital.comreveal

Invests in

AgTechBiotechData & InfrastructureFoodTechHealthtechMedical Devices

Board director at C2i Genomics

Intro paths

→

In turn, Eli can intro founders to C2i Genomics's investors below.

C2i Genomics's investors · 5

Casdin CapitalNew York · since 2021 iGlobe PartnersSingapore · $600K – $6M checks · since 2021 LionBirdTel Aviv · $200K – $500K checks NFXSan Francisco · $250K – $5M checks · since 2021 Section 32Palo Alto · since 2021

Co-founders at C2i Genomics

Asaf ZviranFounder

Board director at Sexton Biotechnologies

Intro paths

→

In turn, Eli can intro founders to Sexton Biotechnologies's investors below.

Sexton Biotechnologies's investors · 2

BioCrossroadsIndianapolis · since 2019 Casdin CapitalNew York · since 2019

Board director at Century Therapeutics, Inc.

Intro paths

→

In turn, Eli can intro founders to Century Therapeutics, Inc.'s investors below.

Century Therapeutics, Inc.'s investors · 3

Casdin CapitalNew York · since 2021 RA CapitalBoston · since 2021 Versant VenturesSan Francisco · $250K – $5M checks · since 2021

Experience

Casdin Capital, LLCChief Investment Officercurrent2011 — presentGreater New York City Area
The Rockefeller UniversityBoard Membercurrent2021 — present
New York Genome CenterBoard Membercurrent2020 — presentNew York, United States
Columbia University School of General StudiesMember, Board of Visitorscurrent2015 — present
Standard BioToolsBoard Membercurrent2022 — present
GeneDxBoard Membercurrent2020 — present
Prominex Inc.Board Membercurrent2018 — presentSan Diego, California
GenomaticaBoard Membercurrent2018 — present
SomaLogicBoard Member2020 — 2024
Tenaya TherapeuticsBoard Member2019 — 2022
EQRxBoard Member2020 — 2022
Exact SciencesBoard Of Directors2017 — 2020Madison, Wisconsin
Relay TherapeuticsBoard Observer2017 — 2019Cambridge, Massachusetts
Magenta TherapeuticsBoard Observer2018 — 2019Cambridge, Massachusetts
Fulcrum TherapeuticsBoard Observer2018 — 2019Cambridge, Ma
InvitaeBoard Observer2013 — 2015
SynapDxBoard Observer2013 — 2015
Alliance BernsteinAnalyst2007 — 2011
Bear StearnsAssociate2007
Cooper Hill PartnersAnalyst2003 — 2006
EDMC ClothingFounder1994 — 2001

Deals · 7

PAIGE.AI, Inc.Board seat

via Casdin Capital · filed Mar 2023 · $39M raise

Cedilla Therapeutics, Inc.Board seat

via Casdin Capital · filed Oct 2021 · $82.6M raise

GenomaticaBoard seat

via Casdin Capital · filed Aug 2021 · $119.1M raise

AbsciBoard seat

via Casdin Capital · filed Mar 2021 · $125M raise

Century Therapeutics, Inc.Board seat

via Casdin Capital · filed Mar 2021 · $160M raise

SomaLogicBoard seat

via Casdin Capital · filed Jan 2021 · $250M raise

Vitruvian NetworksBoard seat

via Casdin Capital · filed Nov 2020 · $75M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

C2i Genomics

Investor

C2i GenomicsCedilla TherapeuticsDNA ScriptLeyden Labs Multiply LabsStandard BioToolsTenaya TherapeuticsThrive Earlier DetectionVerve TherapeuticsVineti

Sources: SEC Form D filings · curated public sources.

Colleagues at Casdin Capital

Alan Huang

Advisor at Casdin Capital

Alex Parker

Advisor at Casdin Capital

Alexandria Fisk

Chief Operating Officer at Casdin Capital

Alley (Welsh) Olshansky

Advisor at Casdin Capital

Angelo Crupi

Chief Compliance Officer at Casdin Capital

Bernie Cooney

Senior Managing Director at Casdin Capital

Brad Weisgerber

Head Trader at Casdin Capital

Carlos Garcia-Echeverria

Advisor at Casdin Capital

Network7

Marc BenioffScout

Co-founder, Chair & CEO of Salesforce

Brook ByersScout

Founder, Kleiner Perkins

Chris GibsonScout

Portfolio Director, Private Equity at Bridges Fund Management Ltd.

Carlo Rizzuto

Managing Director at Versant Ventures

David Schenkein

Investor at GV (Google Ventures)

Jeffrey Bird

Managing Director at Bluebird Ventures

Stephen Knight

President & Senior Managing Partner at F-Prime Capital Partners

Investors connected to Eli in public investor directories — a warm-intro map.

Frequently asked questions

Who is Eli Casdin?: Eli Casdin authored mid-2000s roadmap The Dawn of Molecular Medicine and backs platforms using biological data as decision-making infrastructure while guiding companies to markets via co‑sponsored CM Life Sciences SPACs.
Where does Eli Casdin work?: Eli Casdin is Chief Investment Officer and Founder at Casdin Capital and Board director at C2i Genomics and Board director at Sexton Biotechnologies and Board director at Century Therapeutics, Inc..
What does Eli Casdin invest in?: Eli Casdin invests in AgTech, Biotech, Data & Infrastructure, FoodTech, Healthtech, Medical Devices.
What check size does Eli Casdin write?: Eli Casdin typically writes checks of $100K – $5M.
What boards does Eli Casdin sit on?: Eli Casdin holds tracked board seats at Absci, C2i Genomics, Cedilla Therapeutics, Inc., Century Therapeutics, Inc., Genomatica, PAIGE.AI, Inc., SomaLogic, Vitruvian Networks.
What companies has Eli Casdin invested in?: Investments tracked here include Absci, C2i Genomics, Cedilla Therapeutics, Century Therapeutics, Inc., DNA Script, Leyden Labs, Multiply Labs, SomaLogic, Standard BioTools, Tenaya Therapeutics, Thrive Earlier Detection, Verve Therapeutics, and 1 more.
Where did Eli Casdin go to school?: Eli Casdin studied at Columbia Business School (MBA, Finance - Accounting); Columbia University (Bachelor of Science); University of Vermont.

Same school

Also attended Columbia Business School1,173

Ryan PetersenFounder & CEO of Flexport Aryo TehranianManaging Director at Mayfair Equity Partners Yibo NianInvestment Director at Intel Capital Kesha CashFounder & General Partner at Impact America Fund Mahati SridharPartner, Rise of the Rest at Revolution Giuseppe IademarcoHead of Global Partnership at P101 Ventures

+ 1,167 more

Also attended Columbia University1,304

Ben HorowitzCo-founder & General Partner at Andreessen Horowitz Doug LeonePartner at Sequoia Capital; former Global Managing Partner Chris DixonFounder & Managing Partner of a16z crypto at Andreessen Horowitz Kai-Fu LeeChairman of Sinovation Ventures and CEO of 01.AI Gabriella GiglioHR & Executive Talent at General Catalyst Scott BillerInvestor at GV (Google Ventures)

+ 1,298 more

Also attended University of Vermont161

Patrick VaheyManaging Director at Greenline Community Ventures, Llc Govinda SumbergExecutive Coordinator at Excel Venture Management Dan BorokCo-Founder and Managing Partner at NVP Capital Arun IyerInvestor at Green Flag Audrey StineExecutive Assistant at Sorenson Ventures Melissa Morano AurigemmaChief of Staff at Exceptional Capital

+ 155 more

Also attended Riverdale Country School22

Madeleine GoldbergInvestor at Lerer Hippeau Ryan EngelFounder & Managing Partner at Cade Ventures Daniel MaffezzoliPartner at GATHER VENTURES Caroline ClinePartner at Accretive, LLC Ethan RigelManaging Partner at Gore Range Capital Danny CohenInvestor at RiverPark Ventures

+ 16 more

Shared employers

+ 8 more

Also worked at Magenta Therapeutics5

Carol SuhPartner at ARCH Venture Partners Christina IsacsonPartner at Lightstone Ventures Dima VremenkoFounder at Inkbox Jennifer SchmitkePresident and Chief Operating Officer of Issuer at Consano Bio Kerry WentworthChief Regulatory Officer at Nuvation Bio

Find your path to Eli

About

Contact· self-published, not guessed

Invests in

Board director at C2i Genomics

Intro paths

C2i Genomics's investors · 5

Co-founders at C2i Genomics

Board director at Sexton Biotechnologies

Intro paths

Sexton Biotechnologies's investors · 2

Board director at Century Therapeutics, Inc.

Intro paths

Century Therapeutics, Inc.'s investors · 3

Experience

Deals · 7

Other disclosed investments

Board seats

Investor

Colleagues at Casdin Capital

Network7

Frequently asked questions

Same school

Also attended Columbia Business School1,173

Also attended Columbia University1,304

Also attended University of Vermont161

Also attended Riverdale Country School22

Shared employers

Also worked at GeneDx4

Also worked at Tenaya Therapeutics3

Also worked at Relay Therapeutics14

Also worked at Magenta Therapeutics5